P-064Early outcomes of a pilot study of neoadjuvant chemotherapy with S-1 plus oxaliplatin at dose of 130mg/m2 (nacG-SOX130) in stage III gastric cancer. (20th June 2018) - Konishi, S; Manaka, D; An, H; Nishikawa, Y; Ota, T; Kudo, R; Kawaguchi, K; Hamasu, S; Nishitai, R